Cell-cycle-associated markers and clinical outcome in human epithelial cancers: a tissue microarray study.

Abstract:

:The development and progression of epithelial cancers are the result of an imbalance in signals promoting and inhibiting cellular proliferation and apoptosis. The aim of this study is to evaluate the expression of cell-cycle and apoptosis regulators and correlate them with clinical outcome in the most frequent carcinomas, in order to establish common prognostic biomarkers independent of cancer origin. Using tissue microarrays (TMAs), we have analysed the immuno-expression of Ki-67, Bcl-2, Bax, cyclin D1, cyclin D3, CDK1, CDK2, CDK6, p16, p21, and p27 in a series of 205 carcinomas of the large bowel, breast, lung and prostate (80, 73, 37 and 15 cases, respectively). By univariate analysis, positivity for p27, p16 and Bcl-2 was associated with better overall survival (P<0.0135, P<0.0442 and P<0.0001, respectively). The risk of mortality was 2.3-fold greater in patients without Bcl-2 expression. TMA immunohistochemical analysis identified a subset of epithelial cancers with overlapping alterations in cell-cycle checkpoints, apoptosis regulators and tumour suppressor pathways. We found that in most common epithelial cancers, regardless of origin, Bcl-2 appears to be the key biological factor influencing clinical behaviour.

journal_name

Oncol Rep

journal_title

Oncology reports

authors

Abdulkader I,Sánchez L,Cameselle-Teijeiro J,Gude F,Chávez JE,López-López R,Forteza J,Fraga M

doi

10.3892/or.14.6.1527

keywords:

subject

Has Abstract

pub_date

2005-12-01 00:00:00

pages

1527-31

issue

6

eissn

1021-335X

issn

1791-2431

journal_volume

14

pub_type

杂志文章
  • Mutation analysis of CTNNB1 (beta-catenin) and AXIN1, the components of Wnt pathway, in cervical carcinomas.

    abstract::The components of the Wnt-signaling pathway are mutated in tumors, but the relationship between these components and cervical cancer has not been elucidated. In this study, we used immunohistochemistry, single strand confirmation polymorphism (SSCP) and direct sequencing methods to analyze the mutation and protein exp...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Su TH,Chang JG,Yeh KT,Lin TH,Lee TP,Chen JC,Lin CC

    更新日期:2003-09-01 00:00:00

  • Analysis of the gene expression profile in response to human epididymis protein 4 in epithelial ovarian cancer cells.

    abstract::Currently, there are emerging multiple studies on human epididymis protein 4 (HE4) in ovarian cancer. HE4 possesses higher sensitivity and specificity than CA125 in the confirmative early diagnosis for ovarian cancer. Although much attention has been given to explore its clinical application, research of the basic mec...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4926

    authors: Zhu L,Guo Q,Jin S,Feng H,Zhuang H,Liu C,Tan M,Liu J,Li X,Lin B

    更新日期:2016-09-01 00:00:00

  • Matrix metalloproteinase expression in high grade soft tissue sarcomas.

    abstract::Soft tissue sarcomas comprise a heterogeneous group of mesenchymal tumors with varying biological behavior ranging from indolent tumors with no or minimal metastatic risk to aggressive and frequently metastasizing tumors. Among the more common aggressive adult soft tissue sarcomas are malignant fibrous histiocytoma, s...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Alford SH,Vrana MS,Waite L,Heim-Hall J,Sylvia VL,Williams RP

    更新日期:2007-12-01 00:00:00

  • Role of v-Raf and truncated form RAF1 in the induction of vascular endothelial growth factor and vascularization.

    abstract::In this work we studied the effect of v-raf and different form RAF on up regulation of VEGF gene expression and angiogenesis. In the experiments the truncated forms of RAF1 gene were transfected into the cells of the established human urothelial line HCV-29, otherwise non-angiogenic. The plasmids coding for mitochondr...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Malecki M,Seneta M,Miloszewska J,Trembacz H,Przybyszewska M,Janik P

    更新日期:2004-01-01 00:00:00

  • Vimentin expression is associated with decreased survival in gastric cancer.

    abstract::Gastric cancer rich in stromal tissue, such as diffuse-type disease, carries a poor prognosis. In some cancers, expression of vimentin, a mesenchymal maker, is associated with poor survival. The expression of mesenchymal markers such as vimentin is observed after epithelial-mesenchymal transition (EMT), an important i...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2011.1185

    authors: Otsuki S,Inokuchi M,Enjoji M,Ishikawa T,Takagi Y,Kato K,Yamada H,Kojima K,Sugihara K

    更新日期:2011-05-01 00:00:00

  • Two-port hand-assisted laparoscopic surgery for the 2-stage treatment of a complete bowel obstruction by left colon cancer: a case report.

    abstract::A 69-year-old woman presented to her local clinic with vomiting and abdominal distension. Since a bowel obstruction by left colon cancer was suspected due to a marked dilation of the transverse colon, she was referred to our hospital. On admission, an enema disclosed a complete obstruction at the splenic flexure of th...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Mukai M,Tanaka A,Tajima T,Fukasawa M,Yamagiwa T,Okada K,Sato K,Tobita K,Oida Y,Makuuchi H

    更新日期:2008-04-01 00:00:00

  • Cancer-associated fibroblasts do not respond to combined irradiation and kinase inhibitor treatment.

    abstract::The emergence of radioresistance is a significant issue in the treatment of squamous cell carcinoma. We recently demonstrated that post-radiogenic extracellular signal-regulated kinase (ERK) signaling might decrease radiosensitivity in this cancer type. To further elucidate how tumo...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.2180

    authors: Affolter A,Schmidtmann I,Mann WJ,Brieger J

    更新日期:2013-02-01 00:00:00

  • Activation of PAR2 or/and TLR4 promotes SW620 cell proliferation and migration via phosphorylation of ERK1/2.

    abstract::Protease-activated receptor 2 (PAR2) is a G-protein-coupled receptor and its activation has been associated with the pathogenetic progress in certain cancers. Toll-like receptor 4 (TLR4), one member of Toll-like receptors family, is mainly contributed to the innate immune response. However, recent studies have shown t...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2010.1077

    authors: Zhou B,Zhou H,Ling S,Guo D,Yan Y,Zhou F,Wu Y

    更新日期:2011-02-01 00:00:00

  • Histone deacetylase inhibitors and aspirin interact synergistically to induce cell death in ovarian cancer cells.

    abstract::Histone deacetylase inhibitors (HDIs) as well as non-steroidal anti-inflammatory drugs including aspirin show promise as antineoplastic agents. The treatment with both HDIs and aspirin can result in hyperacetylation of proteins. In this study, we investigated whether HDIs and aspirin interacted in inducing anticancer ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Sonnemann J,Hüls I,Sigler M,Palani CD,Hong le TT,Völker U,Kroemer HK,Beck JF

    更新日期:2008-07-01 00:00:00

  • Analysis of telomerase activity and telomere length in bone and soft tissue tumors.

    abstract::Telomerase activation is prevalent in most epithelial tumors, and may be a critical step in cellular immortalization and carcinogenesis. However, telomerase activity in tumors of mesenchymal origin is not well understood. In the present study, we examined telomerase activity in clinical samples from osteosarcoma and s...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Terasaki T,Kyo S,Takakura M,Maida Y,Tsuchiya H,Tomita K,Inoue M

    更新日期:2004-06-01 00:00:00

  • E2F7, regulated by miR‑30c, inhibits apoptosis and promotes cell cycle of prostate cancer cells.

    abstract::Prostate cancer (PCa) remains a leading cause of mortality among men in the United States and Western Europe. The molecular mechanism of PCa pathogenesis has not been fully elucidated. In the present study, the expression profile of E2F transcription factor 7 (E2F7) in PCa was examined using immunohistochemistry and r...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2020.7659

    authors: Wang Y,Pei X,Xu P,Tan Z,Zhu Z,Zhang G,Jiang Z,Deng Z

    更新日期:2020-09-01 00:00:00

  • Identification and characterization of cancer stem-like cells from primary carcinoma of the cervix uteri.

    abstract::Like many other solid tumors, cervical cancer contains a heterogeneous population of cancer cells. Several investigators have identified putative stem cells from solid tumors and cancer cell lines via the capacity to self renew and drive tumor formation. The aim of this study was to identify and characterize a cancer ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00000545

    authors: Feng D,Peng C,Li C,Zhou Y,Li M,Ling B,Wei H,Tian Z

    更新日期:2009-11-01 00:00:00

  • hRFI overexpressed in HCT116 cells modulates Bcl-2 family proteins when treated with 5-fluorouracil.

    abstract::Exogenous overexpression of hRFI, originally isolated in our laboratory, inhibits not only death receptor-mediated apoptosis but also the mitochondrial apoptosis induced by several chemotherapeutic agents including 5-fluorouracil (5-FU). Recently, it has become clear that hRFI targets and degradates caspase-8 and -10 ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.15.5.1293

    authors: Sasaki S,Watanabe T,Kobunai T,Konishi T,Nagase H,Sugimoto Y,Oka T,Nagawa H

    更新日期:2006-05-01 00:00:00

  • Novel role of semaphorin 3A in the growth and progression of hepatocellular carcinoma.

    abstract::Semaphorin 3A (SEMA3A), a secretory protein, is a founding member of the semaphorin family and functions in both the biological behavior of tumor cells and the modulation of tumor-associated macrophages. However, the role of SEMA3A in hepatocellular carcinoma (HCC) is still not well established. In the present study, ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5616

    authors: Li X,Chen Q,Yin D,Shi S,Yu L,Zhou S,Chen E,Zhou Z,Shi Y,Fan J,Zhou J,Dai Z

    更新日期:2017-06-01 00:00:00

  • Long non‑coding RNA RP1‑163G9.1 is downregulated in gastric adenocarcinoma and is associated with a poor prognosis.

    abstract::The aim of the present study was to investigate the expression, function and underlying molecular mechanism of the long non‑coding (lnc) RNA RP1‑163G9.1 in patients with gastric adenocarcinoma (GA). The expression levels of lncRNA RP1‑163G9.1 were determined in 112 paired clinical GA tissues by reverse transcription‑q...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7127

    authors: Sun B,Dang Y,Zhang F,Li K,Ouyang X,Wang K,Huang Q

    更新日期:2019-06-01 00:00:00

  • Overexpression of SHP2 tyrosine phosphatase promotes the tumorigenesis of breast carcinoma.

    abstract::Expression of Src homology phosphotyrosine phosphatase 2 (SHP2) has been observed in human breast cancer. SHP2 is known to promote cell migration and invasiveness. However, the pathophysiologic role of SHP2 and its relevance to tumorigenesis are still largely unknown. In the present study, we aimed to evaluate the eff...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3201

    authors: Hu Z,Fang H,Wang X,Chen D,Chen Z,Wang S

    更新日期:2014-07-01 00:00:00

  • Genetic progression and divergence in superficial esophageal squamous cell carcinoma by loss of heterozygosity analysis.

    abstract::Esophageal squamous cell carcinoma (SCC) is one of the most common fatal carcinomas worldwide and has some of the most malignant characteristics among gastrointestinal tumors. Although a high frequency of loss of heterozygosity (LOH) for various genes has been observed in esophageal SCCs, these findings do not provide...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Shima H,Hiyama T,Tanaka S,Yoshihara M,Arihiro K,Chayama K

    更新日期:2006-10-01 00:00:00

  • Vascular endothelial growth factor C expression correlates with lymphatic involvement and poor prognosis in patients with esophageal squamous cell carcinoma.

    abstract::Vascular endothelial growth factor C (VEGF-C), a member of VEGF gene family, is considered to induce both lymph node metastasis and lymphatic involvement in various cancers related to lymphangiogenesis. We examined the relationship between VEGF-C expression and clinicopathological features in 112 Japanese patients wit...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.10.6.1747

    authors: Kimura Y,Watanabe M,Ohga T,Saeki H,Kakeji Y,Baba H,Maehara Y

    更新日期:2003-11-01 00:00:00

  • Cancer patients treated with the Banerji protocols utilising homoeopathic medicine: a Best Case Series Program of the National Cancer Institute USA.

    abstract::Although many studies have been conducted on the role of alternative medicine in the treatment of cancer, only a few reports have been published regarding the total regression of malignant tumors. At the PBH Research Foundation (PBHRF), two of the authors have used homoeopathic therapy to treat many patients with vari...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Banerji P,Campbell DR,Banerji P

    更新日期:2008-07-01 00:00:00

  • Fascin is involved in cancer cell invasion and is regulated by stromal factors.

    abstract::The tumor microenvironment plays an important role in cancer growth, invasion and metastasis. The stroma surrounding a tumor is known to contain a variety of factors that can increase angiogenesis, cancer growth and tumor progression. The aim of the present study was to determine the role of fascin in cancer growth an...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6847

    authors: Zhang X,Cho IH,Park JH,Lee MK,Hwang YS

    更新日期:2019-01-01 00:00:00

  • Inhibition of tumor-associated fatty acid synthase activity enhances vinorelbine (Navelbine)-induced cytotoxicity and apoptotic cell death in human breast cancer cells.

    abstract::The lipogenic enzyme fatty acid synthase (FAS) is differentially overexpressed and hyperactivated in a biologically aggressive subset of breast carcinomas and minimally in most normal adult tissues, rendering it an interesting target for anti-neoplastic therapy development. Current trends in the treatment of human bre...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Menendez JA,Colomer R,Lupu R

    更新日期:2004-08-01 00:00:00

  • Translational control of the undifferentiated phenotype in ER‑positive breast tumor cells: Cytoplasmic localization of ERα and impact of IRES inhibition.

    abstract::Using a series of potential biomarkers relevant to mechanisms of protein synthesis, we observed that estrogen receptor (ER)-positive breast tumor cells exist in two distinct yet interconvertible phenotypic states (of roughly equal proportion) which differ in the degree of differentiation and use of IRES-mediated trans...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6332

    authors: Vaklavas C,Zinn KR,Samuel SL,Meng Z,Grizzle WE,Choi H,Blume SW

    更新日期:2018-06-01 00:00:00

  • Induction of DNA damage by deguelin is mediated through reducing DNA repair genes in human non-small cell lung cancer NCI-H460 cells.

    abstract::It has been shown that deguelin, one of the compounds of rotenoids from flavonoid family, induced cytotoxic effects through induction of cell cycle arrest and apoptosis in many types of human cancer cell lines, but deguelin-affected DNA damage and repair gene expression (mRNA) are not clarified yet. We investigated th...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.1622

    authors: Ji BC,Yu CC,Yang ST,Hsia TC,Yang JS,Lai KC,Ko YC,Lin JJ,Lai TY,Chung JG

    更新日期:2012-04-01 00:00:00

  • Identification and characterization of sexual dimorphism‑linked gene expression profile in hepatocellular carcinoma.

    abstract::Hepatocellular carcinoma (HCC) is sexually disparate in humans, with a significantly increased prevalence in males. The molecular mechanisms by which the inhibition or development of liver cancer are facilitated require further investigation with regard to sex factors affecting disease progression. In the present stud...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7217

    authors: Wu Y,Yao N,Feng Y,Tian Z,Yang Y,Zhao Y

    更新日期:2019-09-01 00:00:00

  • Role of triosephosphate isomerase and downstream functional genes on gastric cancer.

    abstract::Triosephosphate isomerase (TPI) is highly expressed in many types of human tumors and is involved in migration and invasion of cancer cells. However, TPI clinicopathological significance and malignant function in gastric cancer (GC) have not been well defined. The present study aimed to examine TPI expression in GC ti...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5846

    authors: Chen T,Huang Z,Tian Y,Wang H,Ouyang P,Chen H,Wu L,Lin B,He R

    更新日期:2017-09-01 00:00:00

  • Metastasis-associated protein is a predictive biomarker for metastasis and recurrence in gastric cancer.

    abstract::The metastasis-associated (MTA) gene family is a critical component of the nucleosome remodeling and histone deacetylase complex, and plays an important role in metastatic processes. We systematically evaluated dysregulation of the MTA family to clarify their clinical significance in gastric cancer (GC). One hundred a...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.5054

    authors: Okugawa Y,Mohri Y,Tanaka K,Kawamura M,Saigusa S,Toiyama Y,Ohi M,Inoue Y,Miki C,Kusunoki M

    更新日期:2016-10-01 00:00:00

  • Downregulation of miR-95 in gastric cancer promotes EMT via regulation of Slug, thereby promoting migration and invasion.

    abstract::miR-95 has been revealed to be aberrantly expressed in multiple types of cancer and to regulate tumor development. Moreover, miR-95 has been revealed to be downregulated in gastric cancer. However, the detailed function of miR-95 in gastric cancer has remained largely unknown. In the present study, we found that miR-9...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6911

    authors: Zhang W,Sun J,Chen J,Xu C,Zhang L

    更新日期:2019-02-01 00:00:00

  • 18F-fluorothymidine PET/CT as an early predictor of tumor response to treatment with cetuximab in human lung cancer xenografts.

    abstract::We investigated whether 18F-fluorothymidine-positron-emission tomography/computed tomography (18F-FLT-PET/CT) is useful for the evaluation of the very early response to anti-epidermal growth factor receptor (EGFR) antibody cetuximab therapy in human lung cancer xenografts. A human tumor xenograft model was established...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2011.1338

    authors: Takeuchi S,Zhao S,Kuge Y,Zhao Y,Nishijima K,Hatano T,Shimizu Y,Kinoshita I,Tamaki N,Dosaka-Akita H

    更新日期:2011-09-01 00:00:00

  • Expression of transglutaminases in human breast cancer and their possible clinical significance.

    abstract::Implicated in several physiologic processes, including tumour-host, some transglutaminases (TGase) have been noted to play a regulatory role in the extracellular matrix in cell adhesion and migration of cancer cells. This study sought to determine the level of expression of TGases and their possible clinical significa...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Jiang WG,Ablin R,Douglas-Jones A,Mansel RE

    更新日期:2003-11-01 00:00:00

  • Dual ErbB1 and ErbB2 receptor tyrosine kinase inhibition exerts synergistic effect with conventional chemotherapy in pancreatic cancer.

    abstract::Patient survival in pancreatic cancer remains poor with gemcitabine (GEM)-based regimens. The target specific molecular agent lapatinib, a dual ErbB1 and ErbB2 receptor tyrosine kinase inhibitor, has shown significant activity against ErbB1 and ErbB2-expressing tumors. Since pancrea...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.2053

    authors: Singla S,Pippin JA,Drebin JA

    更新日期:2012-12-01 00:00:00